Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Institution: The latest non-farm employment report may lead the Federal Reserve to consider pausing rate cuts in November

Institution: The latest non-farm employment report may lead the Federal Reserve to consider pausing rate cuts in November

Bitget2024/10/05 03:35

Tim Horan, Chief Information Officer of the Fixed Income Department at Chilton Trust, stated that strong job creation validates the Federal Reserve's actions and indicates a soft landing is imminent. Horan said that September's higher-than-expected 254,000 new non-farm jobs "allows the Fed to be absolutely pragmatic," even considering pausing (cutting interest rates) in November "to digest election results without worrying about falling behind the curve." With a fairly good performance in the job market, the Fed can calmly adjust monetary policy and understand how elected officials plan to handle government spending. Despite officials avoiding comments on fiscal policy, Horan noted that "the Fed has no choice but to worry" about continuously expanding national debt.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

As traditional automakers cut back on their loss-making electric vehicle businesses, Tesla (TSLA.US) has regained more than half of the US electric vehicle market share.

智通财经2026/09/14 01:06
The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas